Intensive up-front treatment versus a sequential approach in advanced gastric cancer patients: Does first-line matter?

被引：0
|
作者：
Bittoni, Alessandro
Scartozzi, Mario
Pistelli, Mirco
Galizia, Eva
Del Prete, Michela
Giampieri, Riccardo
Faloppi, Luca
Bianconi, Maristella
Maccaroni, Elena
Cascinu, Stefano
机构：
[1] Univ Politecn Marche, Scuola Specializzaz Oncol Med, Ancona, Italy
[2] Univ Politecn Marche, AO Osped Riuniti, Clin Oncol Med, Ancona, Italy
[3] Univ Politecn Marche, Scuola Specializzaz Oncol, Ancona, Italy
[4] Osped Profili, Fabriano, Italy
[5] Univ Politecn Marche, AO Osped Riuniti, Ancona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14663
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study
    Guo, Jhe-Cyuan
    Yang, Shih-Hung
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 634 - 642
  • [32] Does time to treatment matter with venetoclax as first-line treatment for AML?
    Baden, D.
    Wolgast, N.
    Pohlmann, A.
    Steinhaeuser, S.
    Baldus, C. D.
    Fransecky, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 139 - 139
  • [33] first-line cisplatin and irinotecan in advanced or metastatic gastric cancer
    Cheng, T. Y.
    Strava Correa, T.
    Andrade, A. Maria Guimaraes M. C.
    Queiroz Borges Muniz, D.
    Coelho Mesquita, M.
    Luiz Stelko Pereira, G.
    Pimenta Riechelmann, R.
    Marcelo Ghem Hoff, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S439 - S439
  • [34] FIRST-LINE TREATMENT IN HER2-POSITIVE ADVANCED OR METASTATIC GASTRIC CANCER
    Yamaguchi, K.
    Ooki, A.
    Yamada, T.
    Hara, H.
    Asayama, M.
    Tada, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [35] Retrospective Evaluation of the Efficacy of First-Line Treatment of Advanced Gastric Cancer With Docetaxel and Oxaliplatin
    Mao, Zhi-yuan
    Guo, Xiao-chuan
    Su, Dan
    Wang, Li-jie
    Zhang, Ting-ting
    Bai, Li
    CANCER INVESTIGATION, 2015, 33 (01) : 16 - 21
  • [36] Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer
    Amarantidis, K.
    Xenidis, N.
    Chelis, L.
    Chamalidou, E.
    Dimopoulos, P.
    Michailidis, P.
    Tentes, A.
    Deftereos, S.
    Karanikas, M.
    Karayiannakis, A.
    Kakolyris, S.
    ONCOLOGY, 2011, 80 (5-6) : 359 - 365
  • [37] Modified FOLFOX-4 as First-line and Salvage Treatment in Advanced Gastric Cancer
    Baek, Yang Hyun
    Choi, Seok Reyol
    Jang, Jin Seok
    Roh, Myung Hwan
    Lee, Jong Hun
    Won, Jong Jin
    Lee, Chang Min
    HEPATO-GASTROENTEROLOGY, 2011, 58 (105) : 251 - 256
  • [38] Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer
    Ma, Xiaoting
    Yang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] New first-line treatment for gastric/GEJ cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [40] Evaluating the Safety of Up-front Docetaxel in the Treatment of Metastatic and Locally Advanced Prostate Cancer
    Killean, A.
    Law, A.
    Malik, J.
    Sundaramurthy, A.
    McLaren, D.
    CLINICAL ONCOLOGY, 2019, 31 (02) : E21 - E23
12345